Table 3.
Key DVH metrics of patient cohort for rectum and bladder OARs, median (min–max)
OAR | Metric | Constraint | Pre-spacer plans | Post-spacer plans |
Rectum | DMean (Gy) | 15.0 (13.8–16.9) | 13.4a (9.9–14.9) | |
D2cc (Gy) | 36.3 (34.1–37.8) | 31.1a (21.5–33.6) | ||
V18.1 Gy (%) | <50% | 33.0 (30.0–44.2) | 28.0a (11.9–33.4) | |
V29 Gy (%) | <20% | 14.1 (9.4–15.7) | 5.9a (0.0–6.6) | |
V36 Gy (cc) | <1 cc | 2.6 (1.0–4.1) | 0.3a (0.0–1.0) | |
V38 Gy (cc) | 0.5 (0.2–1.7) | 0.1 (0.0–0.3) | ||
Bladder | DMean (Gy) | 8.5 (5.8–11.1) | 9.2 (5.8–15.3) | |
D2 cc (Gy) | 39.9 (38.7–41.1) | 39.6 (38.1–41.6) | ||
V18.1 Gy (%) | <40% | 20.6 (11.0–25.4) | 21.7 (11.9–38.5) | |
V37 Gy (cc) | <10cc | 6.9 (4.4–13.9) | 7.0 (3.4–12.5) |
DVH, dose volume histogram; OAR, organ at risk.
ap ≤ 0.05 considered statistical significant.